Mylan Archives - Express Pharma

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

USFDA restricts imports of 11 Viatris drugs made in Indore facility

Manufacturing capacity of Remdesivir ramped up to around 1.19 cr crore vials a month: Govt

Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms

Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake

USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan

Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart

Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn

US FDA issues warning to Mylan for Telangana plant

Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US